hwa 138 has been researched along with interleukin-8 in 1 studies
| Studies (hwa 138) | Trials (hwa 138) | Recent Studies (post-2010) (hwa 138) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
|---|---|---|---|---|---|
| 22 | 0 | 0 | 23,523 | 1,167 | 9,990 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bengtsson, A; Högåsen, K; Mollnes, TE; Redl, H; Schlag, G | 1 |
1 other study(ies) available for hwa 138 and interleukin-8
| Article | Year |
|---|---|
Effects on complement activation and cytokine (TNF-alpha and IL-8) release of infusion of anti-TNF-antibodies or a xanthine derivative (HWA 138) in septic baboons.
Topics: Animals; Antibodies; Complement Activation; Complement Membrane Attack Complex; Escherichia coli Infections; Hemodynamics; Interleukin-8; Male; Papio; Pentoxifylline; Sepsis; Tumor Necrosis Factor-alpha; Xanthines | 1996 |